Genprex, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3724462037
USD
3.35
0.61 (22.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Genprex, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-21.00
-30.00
-23.00
-20.00
-17.00
-10.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
1.00
1.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-17.00
-24.00
-17.00
-14.00
-13.00
-6.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
-2.00
0.00
Cash Flow from Financing Activities
12.00
10.00
0.00
25.00
41.00
1.00
Net Cash Inflow / Outflow
-5.00
-14.00
-17.00
11.00
25.00
-6.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genprex, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-21.111163
-26.725104
5.00
21.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-0.121078
-3.4759
3.00
96.52%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-17.149088
-14.556434
-3.00
-17.81%
Cash Flow from Investing Activities
0.001166
-14.757316
14.00
100.01%
Cash Flow from Financing Activities
12.011953
109.293747
-97.00
-89.01%
Net Cash Inflow / Outflow
-5.135969
79.979997
-84.00
-106.42%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 30.68% vs -39.15% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-17.15
-24.74
30.68%